Nicox Announces 2026 Conference Participation and Data Presentations

Nicox SA, an international ophthalmology company, has announced its participation in several major conferences in the first half of 2026. The company will make significant scientific data presentations at the American Glaucoma Society (AGS) Annual Meeting, which will take place from February 19 to February 22 in Rancho Mirage, California. During the AGS meeting, multiple presentations will focus on data from the Denali and Whistler studies concerning NCX 470.

Nicox will also attend various conferences, including the Allinvest Securities Biomed Forum in Paris on January 29, the MidCap Event in Frankfurt on February 5, Investor Access in Paris in April, the ARVO Annual Meeting in Denver from May 3 to May 7, and the BIO International Convention in San Diego from June 22 to June 25.

Management team members will be accessible for meetings at these events, offering opportunities for engagement with the scientific and financial communities.